MNTA—The potential magnitude of the Lovenox patent case is starting to be absorbed by the market, IMO. (This matter was well below Wall Street’s radar screen until MNTA’s 2Q15 CC yesterday.)
p.s. AMPH’s 2Q15 CC is one week from today; should be a good listen.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”